Visiting Student Researcher in the Department of Medicine, Infectious Diseases division, at Stanford University School of Medicine. PhD candidate at the University of São Paulo (USP) by the Postgraduate Program in Pharmacy (Physiopathology and Toxicology) of the School of Pharmaceutical Sciences of USP, developing research in the Laboratory of Systems Immunology of the Department of Immunology of the Institute of Biomedical Sciences USP. Degrees (Federal University of São Paulo (Unifesp)): Bachelor of Biotechnology (2017) and Interdisciplinary Bachelor of Science and Technology (2015). Completed a sandwich degree, in Medicinal Biotechnology at the Escola Superior de Saúde, of the Polytechnic Institute of Porto, Portugal. Awarded a PIBIC scholarship, promoted by CAPES, in 2015, with research and development at the Department of Surgery/Discipline of Anesthesiology at UNIFESP. Awarded a scientific initiation scholarship in the Young Talents for Science Program, promoted by CAPES, in 2013. She works in the area of #8203;#8203;Immunology and Pathogenesis of Dengue and Pharmacy. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Dengue outbreaks in Latin America, Africa, and Asia, transmitted by the mosquito Aedes aegypti, represents a state of international public emergency. In 2019, more than 3 million people were affected by the disease in the Americas, with about 30 million reported deaths. Despite the seriousness of this public health problem, there are no specific therapies that effectively combat Dengue an…
Dengue disease is a global health problem that affects approximately 390 million people per year, in over 120 countries but no specific therapy or vaccine is currently available to effectively combat dengue virus (DENV) infection. While most of the individuals infected by DENV are asymptomatic or present uncomplicated symptoms, 5-20% of the patients develop severe dengue (SD) in several d…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 2 / 2 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID